Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Trump Media and Tae Technologies agree to merge in all-stock transaction valued at $6B (CNBC) +++ TRUMP MEDIA Aktie -5,78%

MEDCAP Aktie

>MEDCAP Performance
1 Woche: +2,0%
1 Monat: -2,9%
3 Monate: -13,3%
6 Monate: +20,3%
1 Jahr: -6,2%
laufendes Jahr: -6,0%
>MEDCAP Aktie
Name:  MEDCAP AB SK-,40
Land:  Schweden
Sektor:  Finanzen
ISIN/ Wkn:  SE0009160872 / A2ASQ7
Symbol/ Ticker:  61MA (Frankfurt)
Kürzel:  FRA:61MA, ETR:61MA, 61MA:GR
Index:  -
Webseite:  https://medcap.se/
Profil:  MedCap AB is a healthcare-focused investment compa..
>Volltext..
Marktkapitalisierung:  716.93 Mio. EUR
Unternehmenswert:  730.97 Mio. EUR
Umsatz:  179.74 Mio. EUR
EBITDA:  36.22 Mio. EUR
Nettogewinn:  17.76 Mio. EUR
Gewinn je Aktie:  1.19 EUR
Schulden:  45.68 Mio. EUR
Liquide Mittel:  32.38 Mio. EUR
Operativer Cashflow:  28.67 Mio. EUR
Bargeldquote:  0.83
Umsatzwachstum:  11.3%
Gewinnwachstum:  -13.65%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  MEDCAP
Letzte Datenerhebung:  18.12.25
>MEDCAP Kennzahlen
Aktien/ Unternehmen:
Aktien: 15.04 Mio. St.
Frei handelbar: 78.96%
Leerverk. Aktien: -
Rückkaufquote: 0.11%
Mitarbeiter: 592
Umsatz/Mitarb.: 0.23 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 23.59%
Bewertung:
KGV: 39.56
KGV lG: 28.13
KUV: 3.93
KBV: 5.59
PEG-Ratio: -
EV/EBITDA: 20.18
Rentabilität:
Bruttomarge: 13.53%
Gewinnmarge: 9.88%
Operative Marge: 13.53%
Managementeffizenz:
Gesamtkaprendite: 9%
Eigenkaprendite: 15.18%
>MEDCAP Peer Group

Es sind 50 Aktien bekannt.
 
01.10.25 - 15:01
Abilia acquires LivAssured (Cision)
 
Abilia, a subsidiary to MedCap AB (publ) and part of Business Area Assistive Tech, has signed an agreement to acquire LivAssured B.V. in the Netherlands. The transaction is expected to close shortly. LivAssured's product Nightwatch is a medical device that detects epileptic seizures, and has been developed for more than 10 years with significant commercial progress achieved in Europe in recent years. The company currently has a turnover of approx. 4 MEUR and 15 employees, and an ambitious growth plan. The acquisition complements the offering of Abilia and the Business Area Assistive Tech....
21.07.25 - 12:01
MedCap′s Business Area Specialty Pharma Completes the Acquisition of XGX Pharma (Cision)
 
MedCap's wholly owned subsidiary, Unimedic Pharma AB, has today completed the previously announced acquisition of 100% of the shares in XGX Pharma ApS (“XGX”) in Denmark. The acquisition was announced on June 25, 2025, and has now received the necessary regulatory approval (Foreign Direct Investment) in Denmark....
25.06.25 - 07:36
MedCap′s Business Area Specialty Pharma Acquires XGX Pharma (Cision)
 
MedCap's wholly owned subsidiary, Unimedic Pharma AB, has signed an agreement to acquire XGX Pharma ApS (“XGX”) in Denmark. XGX is a fast-growing specialty pharma company with a pipeline of new products. Currently, XGX's has 7 products on the market, primarily in the Nordics. The pipeline consists of 20 niche products in either late-stage development or registration phase. Expected product launches for this pipeline will be during the coming years. XGX's net sales during the last 12 months amounted to 51m DKK, a growth of 91% compared to the same period previous year. The EBITDA margin...
31.01.25 - 06:30
MedCap′s Business Area Assistive Tech Acquires Danrehab (Cision)
 
The Business Area Assistive Tech within MedCap AB (publ) has signed an agreement to acquire a majority share of Danrehab A/S in Denmark. MedCap acquires 85% of the company and Danrehab's current Managing Director remain a shareholder of 15%. The transaction is expected to close during the first quarter. Danrehab provides hygiene chairs and assistive products to beds with focus on comfort, ease of use, safety and ergonomics for both the individual and the caregiver. The company's revenue in 2024 amounted to approx. 42 MDKK with good profitability and has 16 employees. The purchase...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer lesen kann, der ist niemals einsam. - Prof. Dr. Walter Jens
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!